Viewing Study NCT02672995


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-01-22 @ 5:05 AM
Study NCT ID: NCT02672995
Status: UNKNOWN
Last Update Posted: 2017-08-18
First Post: 2016-01-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
Sponsor: National Taiwan University Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 201511005MINB
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators